{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:30:56Z","timestamp":1790951456518,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP172097"],"award-info":[{"award-number":["MOP172097"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["FRQS52905"],"award-info":[{"award-number":["FRQS52905"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.drugpo.2017.05.033","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T05:45:30Z","timestamp":1496555130000},"page":"239-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection"],"prefix":"10.1016","volume":"47","author":[{"given":"Andreea Adelina","family":"Artenie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-2996","authenticated-orcid":false,"given":"Emmanuel","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Jutras-Aswad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Puzhko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.drugpo.2017.05.033_bib0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.drugpo.2015.05.003","article-title":"Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian trial in acute hepatitis C","volume":"26","author":"Alavi","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.033_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugpo.2013.08.005","article-title":"Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the networks II study","volume":"25","author":"Aspinall","year":"2014","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.033_bib0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1360-0443.2004.00713.x","article-title":"Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: The interface with social factors and service utilization","volume":"99","author":"Bruneau","year":"2004","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.033_bib0020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/cit938","article-title":"Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: A longitudinal study","volume":"58","author":"Bruneau","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.033_bib0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/M16-0816","article-title":"Elbasvir-grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy: A randomized trial","volume":"165","author":"Dore","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.033_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1497.2003.10601.x","article-title":"Effect of primary medical care on addiction and medical severity in substance abuse treatment programs","volume":"18","author":"Friedmann","year":"2003","journal-title":"Journal of General Internal Medicine"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.033_bib0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.drugpo.2015.07.007","article-title":"Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs","volume":"26","author":"Grebely","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.033_bib0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/apt.13538","article-title":"Letter: new treatments for hepatitis C have implications for quality of life in people who inject drugs","volume":"43","author":"Higgs","year":"2016","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.033_bib0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/cid\/ciw111","article-title":"Rising mortality associated with hepatitis C virus in the United States, 2003\u20132013","volume":"62","author":"Ly","year":"2016","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.033_bib0050","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.drugalcdep.2015.06.037","article-title":"Cessation of injecting drug use: The effects of health service utilisation, drug use and demographic factors","volume":"154","author":"Nambiar","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"9791","key":"10.1016\/j.drugpo.2017.05.033_bib0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2017.05.033_bib0060","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.033_bib0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1360-0443.2005.00916.x","article-title":"Primary medical care and reductions in addiction severity: A prospective cohort study","volume":"100","author":"Saitz","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.033_bib0070","article-title":"Treatment scale-up to achieve global HCV incidence and mortality elimination targets: A cost-effectiveness model","author":"Scott","year":"2016","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.drugpo.2017.05.033_bib0075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jech-2014-205224","article-title":"A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs","volume":"69","author":"Spelman","year":"2015","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1016\/j.drugpo.2017.05.033_bib0080","series-title":"Guidelines for the screening, care and treatment of persons with hepatitis C infection","author":"World Health Organization","year":"2014"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.033_bib0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/apt.13269","article-title":"The patient\u2019s journey with chronic hepatitis C from interferon plus ribavirin to interferon- and ribavirin-free regimens: A study of health-related quality of life","volume":"42","author":"Younossi","year":"2015","journal-title":"Alimentary Pharmacology & Therapeutics"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T21:36:08Z","timestamp":1656970568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":17,"alternative-id":["S0955395917301378"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.033","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}